US Stock MarketDetailed Quotes

XTLB XTL Biopharmaceuticals

Watchlist
  • 2.560
  • +0.160+6.67%
Close May 10 16:00 ET
  • 2.470
  • -0.090-3.52%
Post 19:53 ET
13.95MMarket Cap-8533P/E (TTM)

About XTL Biopharmaceuticals Company

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Company Profile

SymbolXTLB
Company NameXTL Biopharmaceuticals
Listing DateSep 1, 2005
Founded1993
CEOMr. Shlomo Shalev
MarketNASDAQ
Employees4
Securities TypeDR
ADS Ratio1.0 : 100.0
Fiscal Year Ends12-31
Address26 Ben-Gurion Street
CityRamat Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5112001
Phone972-3-611-6600
Websitehttp://www.xtlbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Shlomo Shalev
  • Chief Executive Officer and Director
  • --
  • Itay Weinstein
  • Chief Financial Officer
  • --
  • Doron Turgeman
  • Chairman of the Board
  • --
  • Alexander Rabinovich
  • Director
  • --
  • Dr. Jonathan Schapiro
  • Director
  • --
  • Dr. Dobroslav Melamed
  • Independent Director
  • --
  • Osnat Hillel Fain
  • Independent Director
  • --
  • Iris Shapira Yalon
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg